Upgrade to SI Premium - Free Trial

Elanco Animal Health (ELAN): UBS Confident of 'Catalyst-Rich Story in 2026'

March 10, 2026 9:37 AM
UBS analyst Andrea Alfonso reiterated a Buy rating and $31.00 price target on Elanco Animal Health (NYSE: ELAN).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments